{"id":327,"date":"2026-07-24T20:56:58","date_gmt":"2026-07-24T20:56:58","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-news\/?p=327"},"modified":"2026-07-24T20:56:58","modified_gmt":"2026-07-24T20:56:58","slug":"drug-label-requirements","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-news\/2026\/07\/24\/drug-label-requirements\/","title":{"rendered":"DRUG LABEL REQUIREMENTS"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">As per 21 CFR\nPart 201 and 202, US FDA mandates that prescription and certain <a href=\"https:\/\/www.fdahelp.us\/otc-drug-products.html\">OTC drugs<\/a>\nmust be labeled in such way to ensure both patients and healthcare workers have\naccess to clear and safe way to use medications. Labeling requirements vary\ndepending upon the type of drugs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fdahelp.us\/fda-drug-label-review.html\">Drug label compliance<\/a> is important in providing information\nto healthcare providers and consumers and thus protecting public health and severe\nadverse medical events for the patients. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Labeling of\nprescription medication is the most important way to communicate with health\ncare providers, patients, and their caregivers. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Most\nprescription drugs must include FDA approved prescribing information called\npackage insert which includes. <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Drug name (proprietary and\nestablished\/generic name) <\/li><li>Indications and usage <\/li><li>Dosage and administration <\/li><li>Dosage forms and strengths <\/li><li>Contraindications <\/li><li>Warnings and precautions <\/li><li>Adverse reactions <\/li><li>Drug interactions <\/li><li>Use in specific populations (e.g.,\npregnancy, lactation, pediatric, geriatric) <\/li><li>Overdosage <\/li><li>Description <\/li><li>Clinical pharmacology <\/li><li>Nonclinical toxicology <\/li><li>Clinical studies <\/li><li>How supplied\/storage and handling <\/li><li>Patient counseling information<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Over the\ncounter (OTC) drug facts label must include the information below.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Active\ningredient(s)<\/li><li>Purpose<\/li><li>Uses<\/li><li>Warnings<\/li><li>Directions<\/li><li>Other\ninformation (e.g., storage)<\/li><li>Inactive\ningredients<\/li><li>Questions\nor comments (manufacturer contact information)<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Drug labeling\nmust be accurate and should not be misleading. Labels must be clear, readable,\nand consistent with FDA approved prescribing information.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">All drugs\nmarketed in the United States must be listed with unique <a href=\"https:\/\/www.fdahelp.us\/fda-labeler-code.html\">NDC number<\/a>,\nbut not required to appear on all drug labels. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">Liberty Management Group<\/a> as a leading FDA consulting firm provides assistance with <a href=\"https:\/\/www.fdahelp.us\/fda-labeler-code.html\">drug listing<\/a> and <a href=\"https:\/\/www.fdahelp.us\/fda-drug-label-review.html\">label review<\/a> services.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sudha S<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory Consultant<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Email : office@libertymanagement.us<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As per 21 CFR Part 201 and 202, US FDA mandates that prescription and certain OTC drugs must be labeled in such way to ensure both patients and healthcare workers have access to clear and safe way to use medications. Labeling requirements vary depending upon the type of drugs. Drug label compliance is important in &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-news\/2026\/07\/24\/drug-label-requirements\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;DRUG LABEL REQUIREMENTS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[6],"class_list":["post-327","post","type-post","status-publish","format-standard","hentry","category-fda-registration-drug","tag-fda-drug-labeling"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=327"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/327\/revisions"}],"predecessor-version":[{"id":328,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/327\/revisions\/328"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}